Stock analysis, trade plans, and proprietary indicators by Trend Edge.
About Evolus Inc
Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels, which includes various products, such as mid face,… Read full Trend Edge analysis →
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic
Exchange: NASDAQ
IPO Date: February 8, 2018
Headquarters: 520 Newport Center Drive, Newport Beach, CA, United States, 92660
Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.
Timeframe
SMA
Value
Trend Context
Weekly
10-Week SMA
$5.28
Near-term / short-term trend
Weekly
40-Week SMA
$5.88
Medium-term trend
Weekly
80-Week SMA
$8.43
Cyclical trend (business cycle)
Weekly
200-Week SMA
$9.73
Secular trend (multi-year)
Monthly
10-Month SMA
$5.87
Near-term monthly trend
Monthly
20-Month SMA
$8.95
Medium-term monthly trend
Monthly
40-Month SMA
$10.00
Secular monthly trend
Volume Shelves — Support & Resistance
Trend Edge identifies volume shelves: price zones where historically elevated trading volume
creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative
volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.
Price Level
Type
Volume Ratio
Age
$6.70
resistance
1.16x
3 months ago
$8.80
resistance
2.20x
8 months ago
$11.40
resistance
1.56x
11 months ago
$14.60
resistance
1.18x
13 months ago
$16.40
resistance
1.24x
17 months ago
Historical Earnings Reactions (34 events)
Timeframe
Avg Return
Median
Win Rate
Best
Worst
Gap
0.49%
0.86%
55.88%
14.48%
-24.24%
1 Day
0.77%
1.55%
58.82%
19.65%
-28.51%
1 Week
0.79%
-1.25%
41.18%
45.61%
-29.33%
2 Weeks
2.49%
-3.53%
38.24%
95.13%
-22.43%
1 Month
4.84%
-9.07%
39.39%
143.13%
-41.88%
Next earnings: July 23, 2026 (55 days away)
Seasonality & Day-of-Week Patterns
Monthly Seasonality
Month
Avg Return
Win Rate
Samples
Jan
24.1%
75.0%
8
Feb
18.6%
62.5%
8
Mar
-10.7%
22.2%
9
Apr
-3.6%
44.4%
9
May
31.4%
75.0%
8
Jun
1.1%
62.5%
8
Jul
-0.7%
50.0%
8
Aug
4.2%
37.5%
8
Sep
-13.1%
25.0%
8
Oct
-5.3%
62.5%
8
Nov
-1.7%
50.0%
8
Dec
-4.7%
37.5%
8
Day-of-Week Tendencies
Day
Avg Return
Win Rate
Samples
Monday
-0.10%
45.3%
391
Tuesday
0.07%
50.5%
430
Wednesday
0.32%
50.8%
425
Thursday
-0.18%
46.7%
418
Friday
0.34%
48.7%
419
Top Institutional Holders
Institutional holder breakdown coming soon.
Total institutional ownership: 70.0%
Insider Transactions — Smart Summary
Total insider ownership: 14.7%
12-Month Insider Activity Summary
Total Filings
10
Net Value
-$2.2M
Net Shares Change
-183,638
% of Float
-0.4%
C-Suite Filings
7
Clusters Detected
0
Key Insiders
Name
Title
Net Value
Filings
Activity
MOATAZEDI DAVID
President and Chief Executive Officer
-$2.0M
4
1 sell
Stewart Brady
+$204,486
1
1 buy
White Albert G III
+$189,000
1
1 buy
Avelar Rui
Chief Medical Officer and Head of Research and Development
-$177,612.43
3
N/A
Yamagishi-Dressler Tomoko
Chief Marketing Officer
-$42,972.22
1
N/A
Significant Filings
Date
Insider
Title
Net Value
Price After
2025-08-18
Stewart Brady
+$204,486
Transaction at $6.82, now -9.3%
2025-06-10
White Albert G III
+$189,000
Transaction at $9.45, now -34.6%
2025-06-16
MOATAZEDI DAVID
President and Chief Executive Officer
-$1.3M
Transaction at $10.03, now -38.4%
2026-03-18
MOATAZEDI DAVID
President and Chief Executive Officer
-$570,562.376
Transaction at $4.89, now +26.4%
2026-03-20
MOATAZEDI DAVID
President and Chief Executive Officer
-$64,929.117
Transaction at $4.75, now +30.1%
2026-03-18
Avelar Rui
Chief Medical Officer and Head of Research and Development
Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Evolus Inc
(EOLS) powered by Claude Opus — Anthropic's most capable AI model.
The analysis covers five layers:
technical analysis (near-term, medium-term, cyclical, and secular trend, momentum,
volume shelf support and resistance, breakout and breakdown signals),
qualitative analysis (business model, competitive moat, sector dynamics),
insider sentiment (buy and sell signals from executive and director transactions),
share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and
fundamental analysis (valuation, revenue growth, profit margin, earnings quality).
AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit,
stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward.
Whether you are building a long position, initiating a short, or looking for a reversal setup,
AI Consult identifies the highest-probability signal from the current trend.